[Federal Register Volume 79, Number 195 (Wednesday, October 8, 2014)]
[Notices]
[Page 60865]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-24035]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Siemens 
Healthcare Diagnostics, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Siemens Healthcare Diagnostics, Inc., applied to be registered 
as a manufacturer of certain basic classes of controlled substances. 
The DEA grants Siemens Healthcare Diagnostics, Inc. registration as a 
manufacturer of those controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated May 2, 2014, and published 
in the Federal Register on May 15, 2014, 79 FR 27936, Siemens 
Healthcare Diagnostics, Inc., Attn: RA, 100 GBC Drive, Mailstop 514, 
Newark, Delaware 19702, applied to be registered as a manufacturer of 
certain basic classes of controlled substances. No comments or 
objections were submitted to this notice.
    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823(a) and determined that the registration of 
Siemens Healthcare Diagnostics, Inc., to manufacture the basic classes 
of controlled substances is consistent with the public interest and 
with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971. The DEA 
investigated the company's maintenance of effective controls against 
diversion by inspecting and testing the company's physical security 
systems, verifying the company's compliance with state and local laws, 
and reviewing the company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
Ecgonine (9180)............................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The company plans to produce the listed controlled substances in 
bulk to be used in the manufacture of reagents and drug calibrator 
controls which are DEA exempt products.
    In reference to drug code 7370 the company plans to bulk 
manufacture a synthetic tetrahydrocannabinol. No other activity for 
this drug code is authorized for this registration.

    Dated: October 1, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-24035 Filed 10-7-14; 8:45 am]
BILLING CODE 4410-09-P